Clinical Trial Update: Promoting Immunotherapy Efficacy With Low-Dose Liver RT [NA]

View source ↗

Summary

A clinical trial evaluating whether low-dose liver radiotherapy can boost immunotherapy efficacy in non-small cell lung cancer, melanoma, and liver metastases, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Jordan Kharofa | Conditions: Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer | NA | Status: RECRUITING